Objective To analyze the diagnostic value of cerebral hemodynamics detected by point-of-care ultrasound (POCUS) combined with total bilirubin/albumin ratio (B/A) and head magnetic resonance imaging (MRI) for neonatal acute bilirubin encephalopathy (ABE). Methods A single-center retrospective cohort study was conducted. A total of 66 neonates hospitalized from May 2022 to May 2024 due to intermediate-high risk of hyperbilirubinemia[total serum bilirubin (TSB) level ≥342 μmol/L]were included in the study group. Meanwhile, 30 healthy neonates were selected as the control group. The levels of TSB and albumin (ALB) were measured. POCUS was used to detect the peak systolic velocity (PSV), end diastolic velocity (EDV), resistance index (RI) and pulsatility index (PI) of the middle cerebral artery. At the same time, diseased neonates were given a head MRI examination. Neonates in the study group were divided into the ABE group and the non-ABE group according to clinical diagnostic results. The differences in cerebral hemodynamic parameters between the study group and the control group before treatment were analyzed. Based on the changes in hemodynamics in the study group before and after treatment, the diagnostic value of POCUS, B/A, and head MRI for ABE was evaluated using ROC. Results ΔPSV, ΔEDV, ΔPI, ΔRI and B/A in the study group were higher than those in the control group (P<0.05). B/A ratio in the study group was 29.3% higher than that in the control group (95%CI: 18.6%-40.0%, P<0.001). Both ΔPSV and ΔEDV were significantly elevated in the ABE group versus the non-ABE group (P<0.05). Head MRI diagnosed 17 ABE positive cases in the study group, and the Kappa value was 0.686 (95%CI: 0.523-0.849), indicating moderate consistency. ROC analysis showed that the AUCs of POCUS, B/A, and head MRI for diagnosing neonatal ABE were 0.663(95%CI: 0.536-0.775), 0.633 (95%CI: 0.505-0.748), and 0.821 (95%CI: 0.708-0.905), respectively. The efficacy of head MRI was significantly higher than that of POCUS (Z=1.990, P<0.05). The AUC of joint diagnosis using the three was 0.920 (95%CI: 0.826-0.972), significantly greater than that of POCUS, B/A, and head MRI alone (Z=3.284, 3.880, 2.327, P<0.05). Conclusion In this study, the combined use of POCUS, B/A and head MRI can significantly enhance the diagnostic efficacy for ABE in neonates at intermediate-high risk of hyperbilirubinemia. It is suitable for clinical auxiliary diagnosis.
Key words
neonatal acute bilirubin encephalopathy /
point-of-care ultrasound /
total bilirubin/albumin /
magnetic resonance imaging /
diagnosis
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 夏小霞, 陈乐梅, 杨文, 等. 新生儿急性胆红素脑病危险因素分析及风险预测模型的构建[J]. 宁夏医科大学学报, 2025, 47(8): 802-807.
[2] 安琼, 魏媛, 李倩, 等. 基于网络药理学、分子对接和实验验证探讨苹果对溶血致高胆红素血症的影响[J]. 食品科学, 2024, 45(9): 144-152.
[3] 陈家燕, 周智鹏. MRI在新生儿急性胆红素脑病的研究进展[J]. 广东医学, 2023, 44(6): 790-792.
[4] 王媛媛, 杨林峰, 陈涛, 等. 初探定量磁化率成像技术对新生儿高胆红素血症患者潜在脑损伤的预测价值[J]. 中国中西医结合影像学杂志, 2025, 23(1): 84-87, 92.
[5] 党银霞, 杨保旺, 王凡. 床旁即时超声在新生儿休克诊疗中的应用进展[J]. 中国急救医学, 2024, 44(3): 258-262.
[6] 董秀梅, 张春宇, 吴方红, 等. 新生儿行为神经测定评分联合血清胆红素总量/白蛋白比值预测新生儿高胆红素血症并发急性胆红素脑病的临床价值[J]. 中国妇幼保健, 2023, 38(6): 1020-1024.
[7] 邓义, 邓子琴, 段熠, 等. 新生儿高胆红素血症苍白球MRI纹理分析[J]. 临床放射学杂志, 2023, 42(2): 305-310.
[8] 杨静丽, 王建辉.2022版美国儿科学会新生儿高胆红素血症管理指南解读[J]. 中国当代儿科杂志, 2023, 25(1): 11-17.
[9] ZIDAN LK, ROWISHA MA, NASSAR MAE, et al.Mag-netic resonance spectroscopy and auditory brain-stem response audiometry as predictors of bilirubin-induced neurologic dysfunction in full-term jaundiced neonates[J]. Eur J Pediatr, 2024, 183(2): 727-738.
[10] SLAUGHTER JL, KEMPER AR, NEWMAN TB.Technical report: diagnosis and management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation[J]. Pediatrics, 2022, 150(3): e2022058865.
[11] MAHESHWARI V, DĺAZ-GONZÁLEZ DE FERRIS ME, FILLER G, et al. Novel extracorporeal treatment for severe neonatal jaundice: a mathematical modelling study of allo-hemodialysis[J]. Sci Rep, 2024, 14(1): 21910.
[12] HE S, WANG M, ZHU M, et al.Exploring the feasibility and clinical impact of ultrasound microvascular flow imaging in detecting brain injury in hyperbilirubinemia neonates[J]. Sci Rep, 2025, 15(1): 3998.
[13] 李晓燕, 朱亚非, 吴光声, 等. 静息态功能磁共振在新生儿急性胆红素脑病中的应用[J]. 中华全科医学, 2019, 17(5): 801-804.
[14] KAMEL SM, BADR-ELDIN RM, ARAFAT MM, et al.Role of transcranial Doppler in assessment of cerebral blood flow in full term neonates with extreme unconjugated hyperbilirubinemia[J]. J Ultrasound, 2023, 26(1): 175-184.
[15] 李可珍, 仝开军, 王柏平, 等. 磁共振成像结合血清神经肽Y、总胆红素/白蛋白比值构建高胆红素血症患儿并发胆红素脑病预测模型的价值[J]. 中国医刊, 2023, 58(8): 915-919.
[16] 徐璐梦, 巩贺, 刘泉源, 等. 定量MRI在新生儿高胆红素血症脑损伤中的研究进展[J]. 中华放射学杂志, 2025, 59(8): 966-970.
[17] 王卫国, 谢蒙萌, 张兰芳, 等. 头颅MRI联合血清S-100蛋白、NSE对高胆红素血症新生儿脑损伤诊断价值[J]. 中国CT和MRI杂志, 2025, 23(4): 17-20.
[18] 庄毅, 蒋昊翔, 孙磊, 等. 磁共振T1WI及波谱成像在新生儿急性胆红素脑病的临床应用价值[J]. 中国CT和MRI杂志, 2023, 21(05): 4-6.
[19] 董双君, 孙彬, 吴淼, 等. 基于深度学习的多模态MRI辅助诊断新生儿急性胆红素脑病[J]. 中国CT和MRI杂志, 2025, 23(12): 1-4.
[20] 中华医学会儿科学分会新生儿学组, 中华儿科杂志编辑委员会. 新生儿高胆红素血症诊治指南 (2025)[J]. 中华儿科杂志, 2025, 63(4): 338-350.